Viva Biotech Holdings
HKSE: 1873.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chen Cheney Mao
- Employees
- 2,063
- Headquarters
- Shanghai, China
- IPO year
- 2019
- Market cap
- HK$3.4B
- Website
- https://www.vivabiotech.com.cn
Loading 1873…
Loading profile data…Frequently asked questions about 1873
What does Viva Biotech Holdings (1873.HK) do?
Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics;...
Where does 1873.HK trade?
Viva Biotech Holdings (1873.HK) trades on the Hong Kong Stock Exchange.
What sector is 1873.HK in?
Viva Biotech Holdings (1873.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Viva Biotech Holdings?
Chen Cheney Mao is the chief executive officer of Viva Biotech Holdings (1873.HK).
Where is Viva Biotech Holdings headquartered?
Viva Biotech Holdings is headquartered in China.
Does 1873.HK pay a dividend?
Viva Biotech Holdings (1873.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1873.HK go public?
Viva Biotech Holdings (1873.HK) completed its initial public offering in 2019.